慢性阻塞性肺病中的非编码RNA:从致病源到治疗点
Bingbing Ren1,2, Hua Su1, Chang Bao1
1Department of Pulmonary and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Disease, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, China.
Non-coding RNA research
|July 18, 2024
概括
非编码RNAs (ncRNAs) 显著调节慢性阻塞性肺病 (COPD). 了解这些机制揭示了这种广泛的呼吸系统疾病的潜在基于RNA的治疗方法.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个主要的全球健康问题,导致严重的发病率和死亡率.
- 目前对COPD病理生理学的理解需要进一步研究以开发有效的治疗方法.
- 非编码RNAs (ncRNAs) 正在成为各种疾病的关键调节者.
研究的目的:
- 审查ncRNAs在COPD发展和进展中的调控作用.
- 阐明ncRNA参与COPD的潜在分子机制.
- 探索ncRNAs在COPD管理中的治疗潜力.
主要方法:
- 关于ncRNAs和COPD的最近研究的文献综述.
- 分析详细介绍COPD中microRNAs (miRNAs),长非编码RNAs (lncRNAs) 和圆形RNAs (circRNAs) 功能的研究.
- 综合关于基于RNA的治疗策略的信息.
主要成果:
- ncRNAs,包括miRNAs,lncRNAs和circRNAs,在编排COPD病变发生方面发挥着重要作用.
- 特定的ncRNAs涉及到COPD的关键病理过程.
- 有证据表明ncRNAs可以作为COPD的生物标志物和治疗点.
结论:
- ncRNAs是COPD的关键调节者,为疾病机制提供了洞察力.
- 向ncRNAs为COPD的新型治疗干预提供了一个有希望的途径.
- 对ncRNA功能的进一步研究可以推进COPD治疗策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Pathogenesis and Clinical Features
252
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
252
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K


